← All organizations

Orient Europharma Co., Ltd.

For profitWebsite ↗

Also known as: Orient Europharma Co., Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Nov 3, 2022

Timeline

1980s

Jun 1, 1982
Orient Europharma Co., Ltd.— Founded

Drugs by trial phase (16 distinct, 13 trials)

Phase 4 (3 own, 0 via acquisition)

Phase 3 (5 own, 0 via acquisition)

Phase 2 (5 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Other trials (1 own, 0 via acquisition)

niacin

Indications

Studied for

Recent trials (13)

NCT05807529Lead sponsorPhase 1/Phase 2Nov 3, 2022
NCT04185129CollaboratorPhase 4Jan 1, 2020
NCT03771820CollaboratorPhase 2Jun 1, 2019
NCT04229407Lead sponsorN/AMar 12, 2018
NCT04229394Lead sponsorPhase 1Feb 13, 2018
NCT02817113Lead sponsorPhase 1Jun 1, 2016
NCT04349696Lead sponsorPhase 4Feb 11, 2014
NCT02043288Lead sponsorPhase 3Jan 1, 2014
NCT01672008CollaboratorPhase 2Aug 1, 2012
NCT01710007CollaboratorPhase 3Nov 1, 2011
NCT01289574CollaboratorPhase 2Feb 1, 2011
NCT01265849CollaboratorPhase 3Dec 1, 2010
NCT00910741CollaboratorPhase 1/Phase 2May 1, 2009

Details

Founded: Taipei, TW Jun 1, 1982
Last known activity: Nov 3, 2022